ECC 2013 Preview: Expectations for ECC 2013
ECC 2013 Preview: Expectations for ECC 2013
ECC 2013 Preview: Scientific programme highlights
Age and ageing in blood disorders
Rituximab for b-cell lymphoma and EHA overview
Highlights from EHA 2013
Strategies to maintain remission in high risk CD19 lymphoid malignancies
Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma
Importance of the immune system in cancer
Science behind phase I clinical trials: targeting tumour cell development pathways
Comment on progression free survival in lung cancer patients and the GALAXY-1 trial
Crizotinib and molecular testing in advanced non small cell lung cancer
Nintedanib in combination with standard second line therapy in lung cancer